Can CellCept be Given at 500mg Three Times Daily?
No, CellCept (mycophenolate mofetil) should not be dosed at 500mg three times daily—this is not a standard or FDA-approved dosing regimen. The FDA-approved dosing for CellCept is twice daily (BID), not three times daily (TID), with specific total daily doses depending on the indication 1.
FDA-Approved Dosing Regimens
The official FDA labeling for CellCept specifies the following dosing schedules 1:
Renal Transplantation
- Adults: 1g twice daily (total 2g/day) is the recommended dose
- A 1.5g twice daily regimen (3g/day total) was studied but showed no efficacy advantage and had a worse safety profile than the 2g/day regimen
- Pediatrics: 600mg/m² twice daily (maximum 2g/day)
Cardiac Transplantation
- Adults: 1.5g twice daily (total 3g/day)
Hepatic Transplantation
- Adults: 1.5g orally twice daily (total 3g/day) or 1g IV twice daily
Why Not Three Times Daily?
The pharmacokinetics of mycophenolate mofetil support twice-daily dosing. After oral administration, mycophenolate mofetil is rapidly hydrolyzed to its active form (mycophenolic acid), which reaches maximum plasma concentration in approximately 2 hours with 94% bioavailability 2. The drug undergoes hepatic glucuronidation and renal excretion, with pharmacokinetic properties that support a 12-hour dosing interval, not an 8-hour interval.
Alternative Dosing in Autoimmune Conditions
For off-label use in autoimmune conditions (not transplantation), the evidence shows different patterns 3, 4:
- Autoimmune hepatitis: Initial dose typically 1g daily, increased to maintenance of 1.5-2g daily, with doses ranging from 500mg daily to 3g daily 4
- ITP: 500-2000mg per day in adults 3
- Systemic autoimmune rheumatic diseases: Starting at 500mg twice daily, gradually increasing to 1000-1500mg twice daily 5, 6, 5
Even in these off-label contexts, the dosing remains twice daily, not three times daily.
Clinical Pitfalls to Avoid
- Do not confuse total daily dose with dosing frequency: A prescription for "1500mg daily" should be given as 750mg twice daily, not 500mg three times daily
- Budesonide confusion: Budesonide (a different drug sometimes used in autoimmune hepatitis) is dosed at 3mg three times daily 4—do not conflate this with mycophenolate dosing
- Food effects: CellCept should be administered on an empty stomach when possible, as food decreases peak concentration by 40% (though stable renal transplant patients may take it with food if necessary) 1
Correct Approach
If you're considering a 1500mg total daily dose:
- Prescribe 750mg twice daily (every 12 hours)
- Start at 500mg twice daily and titrate up to 750mg twice daily based on tolerance and therapeutic response
- Monitor CBC with differential and liver function tests at baseline, 2-3 weeks after starting, and every 3 months on stable dosing 5, 6, 5
The 500mg three times daily regimen has no evidence base, violates FDA-approved dosing schedules, and creates unnecessary complexity in medication administration that may compromise adherence and therapeutic monitoring.